Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$74.51 USD

74.51
1,138,656

-0.27 (-0.36%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $74.49 -0.02 (-0.03%) 4:34 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 248)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why Investors Should Hold Align Technology (ALGN) Now

Investors are optimistic about Align Technology's (ALGN) Invisalign portfolio expansion and strategic alliances.

Quest Diagnostics' (DGX) New Pact to Get Home Fertility Test

The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.

Here's Why You Should Retain Chemed (CHE) Stock for Now

Investors continue to be optimistic about Chemed (CHE) on the strength of the VITAS Healthcare and Roto-Rooter segments.

Stryker (SYK) Launches Autonomous Guidance System for Surgeries

Stryker's (SYK) fully autonomous Ortho Q Guidance system offers smart and streamlined workflow, leading to enhanced procedural speed and efficiency.

3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio

PacBio's (PACB) product development activities raise optimism about the stock.

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio

Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.

Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

Hologic (HOLX) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Hologic (HOLX) closed at $78.83, marking a -1.29% move from the previous day.

Myomo's (MYO) MyoPro Seeks CMS Classification for Medicare Cover

If this rule is finalized without any changes to reimbursement practices, Myomo's (MYO) MyoPro could be reimbursed in a lump-sum manner by CMS.

DexCom's (DXCM) G7 CGM System Gets Nod From Health Canada

DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.

LabCorp (LH) Partners With Forge Biologics for Gene Therapies

LabCorp's (LH) latest partnership will significantly assist patients gain access to cutting-edge, potentially life-saving medication.

Here's Why You Should Retain Teleflex (TFX) Stock for Now

Revenue growth across global product categories and a broad geographic footprint bode well for Teleflex (TFX).

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio

NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.

Here's Why You Should Buy Exact Sciences (EXAS) Stock Now

Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard growth and raised guidance.

Reasons to Add Inari Medical (NARI) Stock to Your Portfolio

Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a concern.

McKesson (MCK) Hits 52-Week High: What's Driving the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Integer Holdings (ITGR) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Integer Holdings' (ITGR) solid foothold in the broader MedTech space.

Canopy Growth (CGC) Improves Liquidity With Another Selloff

Canopy Growth's (CGC) decision to divest facilities aligns with its organizational transformation plan.

Here's Why You Should Invest in Neogen (NEOG) Stock Now

Investors are upbeat about Neogen (NEOG) owing to strong performance across its Animal Safety and Food Safety segments.

Stryker (SYK) Stock Hits 52-Week High: More Room to Grow?

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

West Pharmaceutical (WST) Hits 52-Week High: More Room to Grow?

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Investors are optimistic about Zimmer Biomet (ZBH) due to the continued procedure recovery and the strength of emerging markets.